FDA

RSS

In November 2022, the U.S. Food and Drug Administration (FDA) released its Final Food Traceability Rule—a new rule that will have wide-reaching impact on food companies. This issue features Part 2 of the results of our survey of food processors' thoughts on this new rule and their plans for compliance.

Amid the pandemic in 2020, federal and state recall coordinators and their leadership teams took a closer look at the existing regulatory recall response efforts in the state of Georgia, and where collaboration exists between the two agencies. After creating a pilot template project in 2021, the recall shadowing concept was expanded to a larger network. Feedback from 12 additional agencies in 2022 strengthened the project to enhance partner integration efforts, with the ultimate goal to better protect public health during recall events.

The U.S. Food and Drug Administration (FDA) has revised the guidance, titled, Labeling of Certain Beers Subject to the Labeling Jurisdiction of FDA, as well as two other guidances, to add “sesame” to the list of major food allergens for labeling purposes.

The U.S. Food and Drug Administration (FDA) has provided an update on its partnership with Mexico’s National Service of Agro-Alimentary Health, Safety, and Quality (SENASICA) and the Mexican Federal Commission for Protection against Sanitary Risk (COFEPRIS). 

In a letter distributed by the U.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition (FDA’s CFSAN) to FDA staff, CFSAN Director Susan T. Mayne, Ph.D. announced that she will be stepping down from her position on May 31, 2023.

On March 8, 2023, the U.S. Food and Drug Administration (FDA) released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. On the same day, the agency’s response to the recent infant formula safety and supply crisis was called into question during a hearing with the U.S. House of Representatives Subcommittee on Health Care and Financial Services Hearing.

The U.S. Food and Drug Administration (FDA) has completed its second premarket consultation for a food made from cultured animal cells intended for human consumption. FDA evaluated the information submitted by GOOD Meat Inc. and has no further questions at this time about the company’s safety conclusion. 

On March 17, 2023, two bipartisan pieces of legislation were introduced to the U.S. House of Representatives with the goal of requiring the U.S. Food and Drug Administration (FDA) to regulate cannabidiol (CBD) products in foods and dietary supplements. 

The U.S. Food and Drug Administration (FDA) has released a report, titled, Activities for the Safety of Imported Seafood. The document shares the steps that FDA is taking to ensure that seafood imported to the U.S. meets food safety requirements and the standards of domestically produced seafood.   

The U.S. Food and Drug Administration (FDA) will release a new prevention strategy aimed at reducing foodborne listeriosis cases and outbreaks associated with the consumption of fresh, soft Queso Fresco-type (QFT) cheeses.